IP Library Granted Patent US 6,844,423
Granted Patent B2
US 6,844,423 · App. 09/961,453 · Granted Jan 18, 2005

Compositions and methods for regulating bacterial pathogenesis

Assignees: Princeton University; University Technologies Transfer International
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,844,423
App. No.
09/961,453
Granted
Jan 18, 2005
Kind
B2
Abstract

The production of a purified extracellular bacterial signal called autoinducer-2 is regulated by changes in environmental conditions associated with a shift from a free-living existence to a colonizing or pathogenic existence in a host organism. Autoinducer-2 stimulates LuxQ luminescence genes, and is believed also to stimulate a variety of pathogenesis related genes in the bacterial species that produce it. A new class of bacterial genes is involved in the biosynthesis of autoinducer-2.

Claims (2)

1. An isolated polypeptide comprising SEQ ID NO:10 produced by expression of an isolated nucleic acid molecule operably linked to a heterologous regulatory sequence that directs expression of the polypeptide.

2. An isolated polypeptide produced by expression of an isolated nucleic acid comprising SEQ ID NO:1 wherein the polypeptide is necessary for biosynthesis of a bacterial extracellular signaling factor that interacts with LuxQ protein, thereby inducing expression of a Vibrio harveyi operon comprising luminescence genes luxCDABE.

Assignments (1)
CONFIRMATORY LICENSE Recorded May 12, 2016
From: PRINCETON UNIVERSITY
To: NATIONAL SCIENCE FOUNDATION
Reel/Frame 038690/0558 →
Continuity (3)
Division 0945397600 · Dec 2, 1999
Provisional Application 6011057000 · Dec 2, 1998
Related Publication 20020107364A1 · Aug 8, 2002